Enovis Quick Ratio 2010-2023 | ENOV
Historical quick ratio values for Enovis (ENOV) over the last 10 years.
| Enovis Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2023-12-31 | $0.43B | $0.37B | 1.16 |
| 2023-09-30 | $0.38B | $0.36B | 1.08 |
| 2023-06-30 | $0.43B | $0.35B | 1.23 |
| 2023-03-31 | $0.39B | $0.35B | 1.13 |
| 2022-12-31 | $0.37B | $0.57B | 0.65 |
| 2022-09-30 | $0.59B | $0.85B | 0.69 |
| 2022-06-30 | $0.68B | $0.81B | 0.83 |
| 2022-03-31 | $1.50B | $1.45B | 1.03 |
| 2021-12-31 | $1.95B | $1.02B | 1.90 |
| 2021-09-30 | $0.95B | $0.98B | 0.97 |
| 2021-06-30 | $0.82B | $0.90B | 0.91 |
| 2021-03-31 | $1.47B | $1.56B | 0.94 |
| 2020-12-31 | $0.80B | $0.81B | 0.98 |
| 2020-09-30 | $0.75B | $0.79B | 0.96 |
| 2020-06-30 | $0.67B | $0.76B | 0.89 |
| 2020-03-31 | $1.02B | $0.82B | 1.25 |
| 2019-12-31 | $0.83B | $0.86B | 0.97 |
| 2019-09-30 | $2.92B | $1.51B | 1.94 |
| 2019-06-30 | $3.04B | $1.60B | 1.90 |
| 2019-03-31 | $1.67B | $1.57B | 1.06 |
| 2018-12-31 | $1.60B | $1.20B | 1.33 |
| 2018-09-30 | $1.47B | $1.07B | 1.37 |
| 2018-06-30 | $1.46B | $1.08B | 1.36 |
| 2018-03-31 | $1.66B | $1.10B | 1.52 |
| 2017-12-31 | $1.64B | $1.10B | 1.50 |
| 2017-09-30 | $1.90B | $1.29B | 1.48 |
| 2017-06-30 | $1.50B | $1.15B | 1.31 |
| 2017-03-31 | $1.35B | $1.08B | 1.25 |
| 2016-12-31 | $1.37B | $1.06B | 1.30 |
| 2016-09-30 | $1.38B | $1.08B | 1.28 |
| 2016-06-30 | $1.36B | $1.09B | 1.25 |
| 2016-03-31 | $1.33B | $1.10B | 1.21 |
| 2015-12-31 | $1.31B | $1.12B | 1.17 |
| 2015-09-30 | $1.55B | $1.21B | 1.29 |
| 2015-06-30 | $1.56B | $1.20B | 1.30 |
| 2015-03-31 | $1.57B | $1.26B | 1.25 |
| 2014-12-31 | $1.63B | $1.28B | 1.28 |
| 2014-09-30 | $1.70B | $1.37B | 1.24 |
| 2014-06-30 | $1.84B | $1.42B | 1.30 |
| 2014-03-31 | $1.87B | $1.31B | 1.42 |
| 2013-12-31 | $1.69B | $1.38B | 1.22 |
| 2013-09-30 | $1.91B | $1.32B | 1.45 |
| 2013-06-30 | $1.82B | $1.25B | 1.46 |
| 2013-03-31 | $1.48B | $1.27B | 1.17 |
| 2012-12-31 | $1.64B | $1.18B | 1.39 |
| 2012-09-30 | $1.71B | $1.22B | 1.40 |
| 2012-06-30 | $1.77B | $1.24B | 1.43 |
| 2012-03-31 | $1.78B | $1.20B | 1.49 |
| 2011-12-31 | $0.30B | $0.24B | 1.23 |
| 2011-09-30 | $0.27B | $0.21B | 1.25 |
| 2011-06-30 | $0.26B | $0.21B | 1.29 |
| 2011-03-31 | $0.26B | $0.21B | 1.24 |
| 2010-12-31 | $0.26B | $0.19B | 1.37 |
| 2010-09-30 | $0.23B | $0.17B | 1.36 |
| 2010-06-30 | $0.22B | $0.14B | 1.56 |
| 2010-03-31 | $0.22B | $0.15B | 1.49 |
| 2009-12-31 | $0.23B | $0.15B | 1.50 |
| 2009-09-30 | $0.23B | $0.16B | 1.49 |
| 2009-06-30 | $0.21B | $0.14B | 1.49 |
| 2009-03-31 | $0.20B | $0.14B | 1.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.779B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
| Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
| 10x Genomics (TXG) | United States | $3.022B | 0.00 |
| Azenta (AZTA) | United States | $3.015B | 163.85 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
| Privia Health (PRVA) | United States | $2.238B | 99.26 |
| Schrodinger (SDGR) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 47.56 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Standard BioTools (LAB) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.451B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.128B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.094B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| ETAO (ETAO) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |